Results 211 to 220 of about 13,547 (264)

Metabolic syndrome is an independent risk factor for time to complete remission of fertility-sparing treatment in atypical endometrial hyperplasia and early endometrial carcinoma patients. [PDF]

Reprod Biol Endocrinol, 2022
Ding Y, Fan Y, Li X, Wang Y, Wang J, Tian L.   +5 more
europepmc   +1 more source

Clinical implications of morular metaplasia in fertility-preserving treatment for atypical endometrial hyperplasia and early endometrial carcinoma patients. [PDF]

Arch Gynecol Obstet, 2022
Wu P, Lv Q, Guan J, Shan W, Chen X, Zhu Q, Luo X.   +6 more
europepmc   +1 more source

Fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer

Cochrane Database of Systematic Reviews, 2018
Nayanar Adela Contreras Perez, Maria-Eulalia Fernandez-Montoli, José Manuel Martínez-García, Jordi Sabadell   +3 more
openaire   +3 more sources

Current research of Assisted Reproductive Technology for women with early endometrial cancer and atypical endometrial hyperplasia after conservative treatment. [PDF]

Front Endocrinol (Lausanne)
Jiang YL, Lin YY, Chen CX, Li YX, Xie HY, Zheng BH.   +5 more
europepmc   +1 more source

Correlation between steroid receptor expression and response to progestational therapy in patients with atypical endometrial hyperplasia or cancer. [PDF]

Gynecol Oncol Rep
Zaiem F, Bedi M, Kheil M, Abujamea A, Jain D, Rosen D, Alkaram W, Kim S, Ali-Fehmi R, Gogoi R.   +9 more
europepmc   +1 more source

Diagnostic Accuracy of Hysteroscopic Scoring System in Predicting Endometrial Malignancy and Atypical Endometrial Hyperplasia. [PDF]

J Midlife Health, 2021
Harika B, Subbaiah M, Maurya DK.
europepmc   +1 more source

Diaphragmatic clear cell carcinoma with Lynch syndrome after surgery for atypical endometrial hyperplasia and ovarian endometriosis: A case report. [PDF]

Mol Clin Oncol
Ueda M, Watanabe T, Momma T, Kanke Y, Kato A, Okabe C, Sato T, Kamo N, Endo Y, Furukawa S, Soeda S, Fujimori K.   +11 more
europepmc   +1 more source

Hysteroscopic Curettage Followed by Megestrol Acetate Plus Metformin as a Fertility-Sparing Treatment for Women with Atypical Endometrial Hyperplasia or Well-Differentiated Endometrioid Endometrial Carcinoma. [PDF]

Clin Med Insights Oncol, 2022
Jing CY, Li SN, Shan BE, Zhang W, Tian WJ, Ren YL, Wang HY.   +6 more
europepmc   +1 more source

Moving forward with actionable therapeutic targets and opportunities in endometrial cancer: NCI clinical trials planning meeting report on identifying key genes and molecular pathways for targeted endometrial cancer trials [PDF]

, 2017
et al,, Mutch, David G
core   +1 more source

Management of Recurrent Endometrial Cancer or Atypical Endometrial Hyperplasia Patients After Primary Fertility-Sparing Therapy. [PDF]

Front Oncol, 2021
Chen J, Cao D, Yang J, Yu M, Zhou H, Cheng N, Wang J, Zhang Y, Peng P, Shen K.   +9 more
europepmc   +1 more source